Morpho Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Morpho heeft een totaal eigen vermogen van ¥3.3B en een totale schuld van ¥0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk ¥3.9B en ¥595.0M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

JP¥0

Schuld

Rente dekkingsratio	n/a
Contant	JP¥2.72b
Aandelen	JP¥3.33b
Totaal verplichtingen	JP¥595.00m
Totaal activa	JP¥3.92b

Recente financiële gezondheidsupdates

We're Not Very Worried About Morpho's (TSE:3653) Cash Burn Rate

May 08

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥3.4B ) 3653 } overtreffen de korte termijn passiva ( ¥552.0M ).

Langlopende schulden: De kortetermijnactiva 3653 ( ¥3.4B ) overtreffen de langetermijnschulden ( ¥43.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 3653 is schuldenvrij.

Schuld verminderen: 3653 had 5 jaar geleden geen schulden.

Schuldendekking: 3653 heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: 3653 heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

Morpho Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

We're Not Very Worried About Morpho's (TSE:3653) Cash Burn Rate

Recent updates

Here's What's Concerning About Morpho's (TSE:3653) Returns On Capital

New major risk - Financial data availability

Investors Give Morpho, Inc. (TSE:3653) Shares A 28% Hiding

Investor sentiment deteriorates as stock falls 27%

Impressive Earnings May Not Tell The Whole Story For Morpho (TSE:3653)

New major risk - Share price stability

Second quarter 2024 earnings released: EPS: JP¥39.76 (vs JP¥22.23 loss in 2Q 2023)

We're Not Very Worried About Morpho's (TSE:3653) Cash Burn Rate

Morpho, Inc. to Report Fiscal Year 2024 Results on Dec 13, 2024

First quarter 2024 earnings released: JP¥16.77 loss per share (vs JP¥47.38 loss in 1Q 2023)

Investor Optimism Abounds Morpho, Inc. (TSE:3653) But Growth Is Lacking

Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)

Morpho, Inc. to Report Q3, 2024 Results on Sep 13, 2024

Morpho, Inc., Annual General Meeting, Jan 30, 2024

Full year 2023 earnings released: JP¥58.49 loss per share (vs JP¥130 loss in FY 2022)

New minor risk - Share price stability

Third quarter 2023 earnings released: JP¥15.60 loss per share (vs JP¥34.51 loss in 3Q 2022)

Second quarter 2023 earnings released: JP¥22.23 loss per share (vs JP¥15.99 loss in 2Q 2022)

First quarter 2023 earnings released: JP¥47.38 loss per share (vs JP¥42.54 loss in 1Q 2022)

Morpho, Inc.’s SoftNeuro Enables 19x Faster Inference of 3D Simulation on Fugaku

Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)

Full year 2022 earnings released: JP¥130 loss per share (vs JP¥147 loss in FY 2021)

Less than half of directors are independent

Morpho, Inc. to Report Q2, 2023 Results on Jun 09, 2023

Third quarter 2022 earnings released: JP¥34.51 loss per share (vs JP¥43.42 loss in 3Q 2021)

Second quarter 2022 earnings released: JP¥15.99 loss per share (vs JP¥21.26 loss in 2Q 2021)

Less than half of directors are independent

Morpho, Inc. to Report Fiscal Year 2022 Results on Dec 09, 2022

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Morpho, Inc. (TSE:3653) announces an Equity Buyback for 300,000 shares, representing 5.54% for ¥360 million.

Second quarter 2021 earnings released: JP¥21.26 loss per share (vs JP¥10.77 profit in 2Q 2020)

First quarter 2021 earnings released: JP¥45.94 loss per share (vs JP¥9.10 loss in 1Q 2020)

Morpho, Inc. to Report Fiscal Year 2021 Results on Dec 10, 2021

Morpho, Inc. to Report Q2, 2021 Results on Jun 11, 2021

Full year 2020 earnings released: JP¥121 loss per share (vs JP¥62.97 profit in FY 2019)

Morpho, Inc. to Report Q1, 2021 Results on Mar 12, 2021

New 90-day low: JP¥1,371

Full year 2020 earnings released: JP¥121 loss per share

Morpho, Inc., Annual General Meeting, Jan 29, 2021

Morpho, Inc.(TSE:3653) dropped from S&P Global BMI Index

Morpho, Inc. to Report Q3, 2020 Results on Sep 11, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven